An experimental vaccine given during pregnancy has shown early promise for protecting infants from a potentially severe respiratory infection. The vaccine, being developed by Pfizer, aims to protect babies from respiratory syncytial virus, or RSV. Most of the time, RSV causes nothing more than a cold. But it can lead to serious lung infections in…  read on >  read on >